Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- BRETEC.HE
- Price
- 0.74
- Stock movement down
- -0.03 (-3.90%)
- Company name
- Bioretec Oy
- Exchange
- (HE ,
- Currency
- EUR )
- Sector
- Healthcare >Medical Devices
- Markedsværdi
- 22.78M
- Ent værdi
- -
- Pris/omsætning
- 2.86
- Pris/bog
- 2.34
- Udbytte afkast
- -
- Udbyttevækst
- -
- Vekst år
- -
- FCF-udbetaling
- -
- Efterfølgende P/E
- -
- Fremtidig P/E
- -
- PEG
- -
- EPS-vekst
- -
- 1 års afkast
- -61.36%
- 3 års afkast
- -
- 5 års afkast
- -
- 10 års afkast
- -
Senest opdateret: 2025-11-25
UDBYTTE
BRETEC.HE betaler ikke udbytte
VÆRDIANSÆTTELSE
Værdiansættelsesforhold
Loading...
Værdiansættelsesforhold-data
| Efterfølgende P/E | - |
| Pris til OCF | - |
| Pris til FCF | - |
| Pris til EBITDA | - |
| EV i forhold til EBITDA | - |
Værdiansættelse (salg/bogført værdi)
Loading...
Værdiansættelse (salg/bogført værdi)-data
| Pris til omsætning | 2.86 |
| Pris til egenkapital | 2.34 |
| EV i forhold til salg | - |
ØKONOMI
Pr. aktie
Loading...
Data pr. aktie
| Aktuelt antal aktier | 30.79M |
| EPS (TTM) | - |
| FCF pr. aktie (TTM) | - |
Resultatopgørelse
Loading...
Resultatopgørelse-data
| Omsætning (TTM) | - |
| Bruttofortjeneste (TTM) | - |
| Driftsindkomst (TTM) | - |
| Nettoindkomst (TTM) | - |
| EPS (TTM) | - |
| EPS (1 år frem) | -0.32 |
Marginer
Loading...
Marginer-data
| Bruttomargin (TTM) | - |
| Driftsmargin (TTM) | - |
| Fortjenstmargin (TTM) | - |
Balance
Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Balancedata
| Kontanter | 0.00 |
| Nettotilgodehavender | 0.00 |
| Omsætningsaktiver i alt | 9.75M |
| Goodwill | 0.00 |
| Immaterielle aktiver | 622.50K |
| Ejendomme, anlæg og udstyr | 0.00 |
| Sum aktiver | 11.47M |
| Kreditor | 0.00 |
| Kortfristet/nuværende langsigtet gæld | 0.00 |
| Summen af kortfristede forpligtelser | 1.30M |
| Sum gæld | 1.74M |
| Aktionærernes egenkapital | 9.74M |
| Materielle nettoaktiver | 0.00 |
Likviditet
Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Kontantstrøm-data
| Likviditet fra driften (TTM) | - |
| Investeringsudgifter (TTM) | - |
| Fri pengestrøm (TTM) | - |
| Udbetalt udbytte (TTM) | - |
Finansiel indkomst
Loading...
Opret en gratis konto eller log ind for at få adgang til dette diagram
Data om finansiel indkomst
| Egenkapitalafkast | - |
| Afkast af aktiver | - |
| Afkast af investeret kapital | - |
| Kontant afkast af investeret kapital | - |
INFORMATION OM AKTIER
Aktiediagram
Loading...
Aktiekurs-data
| Åbning | 0.78 |
| Daglig høj | 0.78 |
| Daglig lav | 0.73 |
| Daglig volumen | 49K |
| Højeste gennem alle tider | 3.26 |
| 1 års analytiker estimat | 1.20 |
| Beta | - |
| EPS (TTM) | - |
| Udbytte pr. aktie | 0.00 |
| Ex-div dato | - |
| Næste dato for resultatpræsentation | - |
Nedsidepotensial
Loading...
Nedsidepotensial-data
| BRETEC.HE | S&P500 | |
| Nuværende prisfald fra top notering | -77.30% | -1.80% |
| Højeste prisfald | -77.30% | -19.00% |
| Højeste efterår dato | 25 Nov 2025 | 8 Apr 2025 |
| Gennemsnitlig fald fra toppen | -42.08% | -2.73% |
| Gennemsnitlig tid til nyt højdepunkt | - | 6 days |
| Maks. tid til nyt højdepunkt | 283 days | 89 days |
OPLYSNINGER OM VIRKSOMHEDEN
Markedsværdi
22.78M
Markedsværdi kategori
Small-cap
Beskrivelse
Bioretec Oy, a medical device company, develops, manufactures, and markets bioresorbable orthopedic implants for the repair of bone and soft tissue injuries in children and adults worldwide. The company offers Activa IM-Nail, a bioabsorbable option for pediatric forearm intramedullary nailing; ActivaNail, an implant that is be used in upper or lower limbs to ensure successful bone regeneration; ActivaPin, a bioabsorbable implant for upper and lower limb fractures; and ActivaScrew, an absorbable surgical implant that is used in fracture treatment, osteotomy, arthrodesis, and bone graft surgery. It also provides ActivaScrew Cannulated that offers a range of fully threaded and partially threaded cannulated screws for fixation of fractures and osteotomies; ActivaScrew Interference, a tool for multiple uses regarding bone fractures, osteotomies, arthrodesesm, and bone grafts; ActivaScrew Interference TCP, a biocomposite interference screw; and RemeOs Screw, a magnesium screw implants. The company was formerly known as BCI Bioabsorbable Concepts Oy. The company was incorporated in 1998 and is headquartered in Tampere, Finland.
Personale
0
Hjemmeside
Investor relationer
-
SEC-indsendelser
Adm. direktør
Land
Finland
By
Aktietype
-
CCC-status
-
Utbyttefrekvens
-
ARRANGEMENTER OG PRÆSENTATIONER
ArrangementerPræsentationer
Loading...
FORSTÅ FORRETNINGEN
Loading...
NYHEDER OM VIRKSOMHEDEN
Alle nyhederPressemeddelelser
This announcement summarizes Bioretec Ltd's business review for January–September 2025. The complete business review is attached to this release as a PDF file and available on the company's website at...
13. november 2025
Bioretec Ltd is initiating change negotiations in accordance with the Finnish Act on Co-operation within Undertakings. The aim of the negotiations is to streamline and reorganize operations in order t...
12. november 2025
Bioretec announced on 27 October 2025 that it will adjust and restate its previously reported figures for H1/2025.
31. oktober 2025
On 22 November 2024, Bioretec Ltd ("Bioretec" or the "Company"), announced through a press release a new sales and distribution agreement with Tri-State Biologics ("TSB"), enabling the sale and distri...
27. oktober 2025
On 12 September 2025, Bioretec Ltd ("Bioretec" or the "Company"), announced that the revised timeline of the planned commercialization of the DrillPin in the U.S. was then not expected to have a mater...
27. oktober 2025
Bioretec Ltd, a pioneer in absorbable orthopedic implants, announced today that the Centers for Medicare & Medicaid Services (CMS) has granted Transitional Pass-Through Payment (TPT) status for the co...
1. oktober 2025
Bioretec Ltd., a pioneer in bioresorbable orthopedic implants, today announced the appointment of Dr. Christopher W. DiGiovanni to its Scientific Advisory Board (SAB).
4. september 2025
Bioretec Ltd, a pioneer in absorbable orthopedic implants, announced today the appointment of Jordy Winters as Vice President of Sales Outside U.S. (OUS; Europe and Rest of the World) and member of th...
2. september 2025
Bioretec Ltd., a pioneer in absorbable orthopedic implants, announced today the appointment of Sarah van Hellenberg Hubar-Fisher as Chief Executive Officer (CEO) effective immediately. Van Hellenberg ...
27. august 2025
Bioretec Ltd Company announcement 14 August 2025 at 8.00 am EEST
14. august 2025
Næste side